How machine learning is advancing precision medicine and pharmacogenomics
By
Dr. Sai Balasubramanian, M.D., J.D.
Summary
The article discusses how machine learning is transforming precision medicine and pharmacogenomics by moving beyond traditional evidence-based medicine that relies on statistical averages. It explains that while conventional medicine prescribes treatments based on what works for the majority, ML enables personalized treatment approaches by analyzing individual patient data, genetic profiles, and biomarkers. The piece highlights how ML algorithms can identify patterns in complex biological data to predict drug responses, optimize dosing, and reduce adverse reactions for specific patient subgroups, ushering in a new era of tailored healthcare.
Source
bskyHow machine learning is advancing precision medicine and pharmacogenomicsforbes.comKey quotes
· 3 pulledMedicine has always operated as an 'evidence based' field, meaning that it generally pursues experimentation to gather evidence to support a specific claim for diagnostic and treatment success.
Medications often operate on the laws of statistical averages: if an overwhelming majority of people respond positively to a specific drug, then it is generally prescribed more broadly as applicable to a wider part of the population, until the evidence proves otherwise.
However, this also means that a percentage of the population will be impacted by the margin of error and may experience side effects or lack of efficacy.
You might also wanna read

AI Advances in Drug Discovery: From Data Integration to Dual-Action Cancer Drug Design
The article discusses recent advancements in AI-driven drug discovery, highlighting two key developments: 1) Analytica 2026, an event focuse
How AI is reshaping oncologists' trust in their own clinical judgment
This article explores how oncologists develop clinical intuition over years of practice and how the rise of AI in medicine is challenging th
How LLMs Are Transforming Preclinical Drug Discovery Data Access
The article discusses how Large Language Models (LLMs) are being applied to preclinical drug discovery to help researchers efficiently acces

Mayo Clinic researcher explains how AI is accelerating the path to medical cures
Mayo Clinic's Dr. Cui Tao discusses how artificial intelligence and automation are transforming biomedical research by enabling researchers
Harmonic Discovery: AI-powered platform for precision drug design launches on Product Hunt
Harmonic Discovery is a biotech platform that uses machine learning and generative chemistry to design safer, more effective medicines. The
Reflections on 2024 Bio-ML Predictions: Generative Chemistry and Molecular Dynamics Challenges
The article reflects on the author's 2024 predictions about bio-ML (biological machine learning) from a 2026 perspective, focusing on genera

Comments
Sign in to join the conversation.
No comments yet. Be the first.